Condition: Spinocerebellar Ataxia · Sponsor: Ataxia Study Group
The key goals of EUROSCA-NHS is to determine and compare the rate of disease progression in SCA1, SCA2, SCA3 and SCA6 including determination of the order and occurrence of non-ataxia symptoms, assessment of activities of daily living (ADL) and quality of life (QoL), and identification of predictors of disease progression and survival.
This description comes directly from the study's public registry record.
Thomas Klockgether, Prof. Dr. · +4922828715736 · thomas.klockgether@ukb.uni-bonn.de
Heike Jacobi, Dr. · heike.jacobi@ukb.uni-bonn.de
Always discuss trial participation with your own doctor first.
| Department of Neurology, Medical University, Innsbruck | Innsbruck, Austria | Active Not Recruiting |
| Université Libre de Bruxelles (ULB), Neurology Service - ULB Hôpital Erasme, ULB Laboratory of Experimental Neurology | Brussels, Belgium | Active Not Recruiting |
| Hôpital de la Pitié-Salpêtrière, Département de Génétique | Paris, France | Active Not Recruiting |
| Department of Neurology, St. Josef Hospital, University Hospital of Bochum | Bochum, Germany | Active Not Recruiting |
| Department of Neurology, University of Bonn | Bonn, Germany | Recruiting |
| Department of Neurology, University Clinic Essen, University of Duisburg-Essen | Essen, Germany | Active Not Recruiting |
| Department of Neurology, University of Frankfurt | Frankfurt, Germany | Active Not Recruiting |
| Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tübingen | Tübingen, Germany | Active Not Recruiting |
| Department of Medical Genetics, University of Pecs | Pécs, Hungary | Active Not Recruiting |
| Department of Neurology, Zala County Hospital | Zalaegerszeg, Hungary | Active Not Recruiting |
| Fondazione-IRCCS Istituto Neurologico Carlo Besta | Milan, Italy | Active Not Recruiting |
| Department of Neuroscience, Federico II University Naples | Naples, Italy | Active Not Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02440763